Organization
Yana Najjar
4 clinical trials
Clinical trial
Profiling and Reversing Metabolic Insufficiency in the Tumor Microenvironment in Advanced Melanoma: A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced MelanomaStatus: Recruiting, Estimated PCD: 2027-01-01
Clinical trial
Phase I Pilot Study of RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node MetastasisStatus: Recruiting, Estimated PCD: 2026-01-31
Clinical trial
A Phase II Trial of Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced MelanomaStatus: Active (not recruiting), Estimated PCD: 2024-04-15
Clinical trial
Evolution of Metabolic and Immune Dysfunction in In-transit MelanomaStatus: Recruiting, Estimated PCD: 2027-03-01